Showing results (231-240 of 304) with videos related to

Sort By:
Pageof 31
Breast (Edinburgh, Scotland)|February 6, 2026
Epigenetic and fragment-based profiling across CDK4/6 inhibitors in first-line HR+/HER2- metastatic breast cancer. An ancillary analysis of the MAGNETIC.1 studyClaudia Noto, Lorenzo Foffano, Fabiola Giudici, et al.
The Lancet. Oncology|September 9, 2019
Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysisMario Giuliano, Francesco Schettini, Carla Rognoni, et al.
Clinical Nutrition (Edinburgh, Scotland)|June 18, 2020
Prognostic role of visceral fat for overall survival in metastatic colorectal cancer: A pilot studyDebora Basile, Michele Bartoletti, Maurizio Polano, et al.
Breast Cancer Research : BCR|October 2, 2023
Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysisLorenzo Gerratana, Andrew A Davis, Marko Velimirovic, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 1, 2020
Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulvaMichele Bartoletti, Roberta Mazzeo, Marco De Scordilli, et al.
Journal of Geriatric Oncology|June 25, 2020
The SENECA study: Prognostic role of serum biomarkers in older patients with metastatic colorectal cancerCamilla Lisanti, Debora Basile, Annamaria Parnofiello, et al.
The Oncologist|March 24, 2020
The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte-to-Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic Colorectal CancerDebora Basile, Silvio Ken Garattini, Carla Corvaja, et al.
NPJ Breast Cancer|December 18, 2024
Clinico-pathological predictors of radiologic complete response to first-line anti-HER2 therapy in metastatic breast cancerLinda Cucciniello, Eva Blondeaux, Claudia Bighin, et al.
JAMA Network Open|February 26, 2025
Racial Differences in ctDNA Profiles, Targeted Therapy Use, and Outcomes in Metastatic Breast CancerEmily L Podany, Lorenzo Foffano, Lorenzo Gerratana, et al.
Breast (Edinburgh, Scotland)|March 17, 2024
Gender minorities in breast cancer - Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patientsFederica Miglietta, Letizia Pontolillo, Carmine De Angelis, et al.
Pageof 31